A Study of Tanezumab in Adults With Chronic Low Back Pain

NCT00876187 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1359

Enrollment

INDUSTRY

Sponsor class

Conditions

Low Back Pain

Interventions

BIOLOGICAL: Tanezumab 20 mg IV
DRUG: Placebo for naproxen
BIOLOGICAL: Tanezumab 10 mg IV
DRUG: Placebo for naproxen
BIOLOGICAL: Tanezumab 5 mg IV
DRUG: Placebo for naproxen
BIOLOGICAL: Placebo for tanezumab
DRUG: Naproxen
BIOLOGICAL: Placebo for tanezumab
DRUG: Placebo for naproxen

Sponsor

Pfizer